ARTICLE | Distillery Therapeutics
Neurology
August 9, 2017 6:40 PM UTC
Mouse studies suggest inhibiting ARNTL could help treat tuberous sclerosis complex (TSC)-associated sleep disorder. In cortical tissue samples from a mouse model of TSC, levels of ARNTL were higher an...
BCIQ Company Profiles
BCIQ Target Profiles
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL) (BMAL1)